Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03967990 · ClinicalTrials.gov registry record · NA
Corn and Heart Health Study
A NA study, sponsored by Arizona State University.
- Completed
- Registry status
- NA
- Development phase
- 58
- Enrollment target
NCT03967990: Completed NA study, sponsored by Arizona State University.
NCT03967990 is a NA study that has completed, run by Arizona State University. The registered enrollment target is 58 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03967990, a NA study, has completed, sponsored by Arizona State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the effects of 3 different corn flours: (1) whole grain corn flour, (2) 50% refined corn flour + 50% corn bran derived from whole corn meal, and (3) refined corn flour, on cardio-metabolic outcomes and changes in the gut microbiome.
Primary Outcome
Serum LDL cholesterol concentrations will be measured at the 0 and 4 weeks for each cornmeal intervention
Interventions
- OTHER Refined cornmeal flour
- OTHER 50/50 refined cornmeal-bran mix
- OTHER Whole grain cornmeal flour
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2018-03-20 |
| Est. Completion | 2023-10-30 |
| Phase | NA |
What the finished NCT03967990 record still lists
NCT03967990 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 58 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 3 interventions - of which Refined cornmeal flour is the first listed.
NCT03967990 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03967990 about?
NCT03967990 is a clinical study titled "Corn and Heart Health Study". The purpose of this study is to investigate the effects of 3 different corn flours: (1) whole grain corn flour, (2) 50% refined corn flour + 50% corn bran derived from whole corn meal, and (3) refined corn flour, on cardio-metabolic outcomes and changes in the gut microbiome.
What is the current status of trial NCT03967990?
This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2018-03-20. Estimated completion is 2023-10-30.
What interventions are being tested in trial NCT03967990?
The interventions under investigation include: Refined cornmeal flour (OTHER), 50/50 refined cornmeal-bran mix (OTHER), Whole grain cornmeal flour (OTHER).
Who is sponsoring clinical trial NCT03967990?
This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03967990's enrollment target sits among peer trials
58 1256th of 2000 higher than 740 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI